GITNUX MARKETDATA REPORT 2024

Hemorrhoid Treatment Devices Industry Statistics

The hemorrhoid treatment devices industry is expected to experience steady growth due to increasing prevalence of hemorrhoids and a rising aging population globally.

Highlights: Hemorrhoid Treatment Devices Industry Statistics

  • The global hemorrhoid treatment devices market size was valued at USD 576.9 million in 2018.
  • The market is expected to show a compound annual growth rate (CAGR) of 4.8% between 2019 and 2026.
  • Rubber band ligation device type accounts for the largest market share of over 44% in 2018.
  • North America accounted for the largest revenue share in the world market in 2018.
  • The Asian market is expected to show the fastest CAGR during the forecast period.
  • Hospitals were the largest end-use segment in 2018, accounting for more than 40% industry share.
  • Asia Pacific is anticipated to witness lucrative growth over the forecast period, with a CAGR of around 7.0% from 2019 to 2026.
  • Ambulatory surgery centers segment is expected to witness the fastest growth over the forecast period.
  • Sclerotherapy segment is projected to be a highly attractive segment during the forecast period.

Table of Contents

The Latest Hemorrhoid Treatment Devices Industry Statistics Explained

The global hemorrhoid treatment devices market size was valued at USD 576.9 million in 2018.

The statistic indicates that the global market for hemorrhoid treatment devices had a total value of USD 576.9 million in 2018. This suggests a significant market presence and demand for devices aimed at treating hemorrhoids, a common medical condition characterized by swollen and inflamed veins in the rectum and anus. The market size value reflects the total revenue generated by the sales of hemorrhoid treatment devices worldwide in that year. This statistic implies a substantial market opportunity for manufacturers and suppliers of such devices, indicating a growing awareness and need for effective solutions to address hemorrhoids on a global scale.

The market is expected to show a compound annual growth rate (CAGR) of 4.8% between 2019 and 2026.

The statement indicates that the market is forecasted to experience a consistent growth rate of 4.8% annually from 2019 to 2026, on average. This growth rate is measured using the compound annual growth rate (CAGR) metric, which takes into account the effect of compounding over the entire period. Essentially, this means that the market is anticipated to expand steadily at a rate of 4.8% each year over the specified time frame, reflecting the potential for ongoing growth and indicating a positive outlook for the market during this period.

Rubber band ligation device type accounts for the largest market share of over 44% in 2018.

The statistic indicates that the rubber band ligation device type holds the highest market share in 2018, constituting over 44% of the total market. This suggests that among all types of devices used for rubber band ligation procedures, the rubber band ligation device type is the most widely used or preferred by healthcare providers or patients. This dominance in market share could be attributed to various factors such as effectiveness, ease of use, cost-efficiency, or availability of the device. Understanding the market share of different device types is important for companies manufacturing these devices, healthcare providers, and policymakers to make informed decisions about resource allocation, research, and development in this field.

North America accounted for the largest revenue share in the world market in 2018.

The statistic “North America accounted for the largest revenue share in the world market in 2018” indicates that out of all the regions across the globe, North America generated the highest amount of revenue within the specified market in the year 2018. This suggests that businesses, industries, or economic activities in North America were the most profitable and successful compared to other regions during that time period. The statistic highlights the significant contribution of North America towards the overall revenue generated in the global market in 2018, showcasing the region’s economic strength and dominance in the specified market sector.

The Asian market is expected to show the fastest CAGR during the forecast period.

This statement implies that the Compound Annual Growth Rate (CAGR) of the Asian market is projected to be higher than that of other regions over the forecast period. CAGR is a measure of the annual growth rate of an investment over a specified time period. In this context, it suggests that the Asian market is anticipated to experience faster growth in terms of economic activity, market size, or other relevant metrics compared to other markets such as North America, Europe, or Latin America. This trend may be driven by various factors such as population growth, rising disposable incomes, favorable government policies, or increasing adoption of technology within the Asian market.

Hospitals were the largest end-use segment in 2018, accounting for more than 40% industry share.

The statistic indicates that in 2018, hospitals were the largest consumer group within a certain industry, representing over 40% of all products or services consumed within that industry. This suggests that hospitals played a significant role in driving demand and revenue for the industry during that time period. The high market share held by hospitals highlights their importance as a key customer segment and underscores the potential impact they can have on the overall performance and dynamics of the industry. Understanding and catering to the needs of hospitals may be crucial for businesses operating within this industry to effectively compete and succeed.

Asia Pacific is anticipated to witness lucrative growth over the forecast period, with a CAGR of around 7.0% from 2019 to 2026.

The statement “Asia Pacific is anticipated to witness lucrative growth over the forecast period, with a CAGR of around 7.0% from 2019 to 2026” indicates that the Asia Pacific region is expected to experience significant economic expansion over the specified time frame. The Compound Annual Growth Rate (CAGR) of around 7.0% signifies the average annual growth rate of a specific indicator, in this case likely referring to economic output or market size. A CAGR of 7.0% suggests robust and steady growth in the region’s economy, which can be attributed to factors such as increasing investments, technological advancements, expanding markets, and favorable government policies. This prediction implies potential opportunities for businesses and investors operating within or looking to enter the Asia Pacific market during the forecast period.

Ambulatory surgery centers segment is expected to witness the fastest growth over the forecast period.

This statistic indicates that among all segments within the healthcare sector, ambulatory surgery centers are projected to experience the most rapid expansion over the upcoming forecast period. Ambulatory surgery centers offer same-day surgical procedures that do not require an overnight hospital stay, providing cost-effective and convenient options for patients. The anticipated growth in this sector may be driven by factors such as advancements in technology, increasing demand for outpatient procedures, and efforts to reduce healthcare costs. This trend suggests that healthcare providers and investors could potentially benefit from focusing on or investing in ambulatory surgery centers as a promising area for future growth and development within the healthcare industry.

Sclerotherapy segment is projected to be a highly attractive segment during the forecast period.

The statistic that the sclerotherapy segment is projected to be a highly attractive segment during the forecast period likely indicates that this particular treatment method for varicose veins is expected to experience significant growth and demand in the coming time frame. This projection could be based on various factors such as the effectiveness of sclerotherapy, increasing awareness among patients and healthcare providers, advancements in technology related to the procedure, or favorable reimbursement policies. The attractiveness of this segment could also be supported by factors such as cost-effectiveness, minimal invasiveness, and relatively quick recovery times associated with sclerotherapy compared to other treatment options. Overall, this statistic suggests that the sclerotherapy segment is poised for growth and may present promising opportunities for healthcare providers and stakeholders in the industry.

References

0. – https://www.www.grandviewresearch.com

1. – https://www.www.prnewswire.com

2. – https://www.www.globenewswire.com

3. – https://www.www.transparencymarketresearch.com

How we write our statistic reports:

We have not conducted any studies ourselves. Our article provides a summary of all the statistics and studies available at the time of writing. We are solely presenting a summary, not expressing our own opinion. We have collected all statistics within our internal database. In some cases, we use Artificial Intelligence for formulating the statistics. The articles are updated regularly.

See our Editorial Process.

Table of Contents

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!